NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Eli Lilly and Company
Eli Lilly and Company
Stanford University
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Heidelberg University